BMRN

BioMarin Pharmaceutical Inc. News Headlines

$61.09
*  
0.06
0.1%
Get BMRN Alerts
*Delayed - data as of Jul. 30, 2014  -  Find a broker to begin trading BMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14)
1/22/2014 6:36:00 AM - Seeking Alpha

Pipeline Progress at BioMarin - Analyst Blog
1/15/2014 7:20:01 PM - Zacks.com

Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)
1/11/2014 11:46:00 AM - Investopedia

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets
1/8/2014 9:56:51 AM - MT Newswires

Sector Update: Healthcare
1/8/2014 9:56:13 AM - MT Newswires

Notice of Allowance Received by Alkermes - Analyst Blog
1/7/2014 5:21:01 PM - Zacks.com

BioMarin Pharmaceutical Inc. (BMRN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/3/2014 8:00:01 AM - Zacks.com

SA PRO: Top Long And Short Ideas, Tuesday December 24
12/25/2013 7:30:00 AM - Seeking Alpha

BioMarin: All Drivers Will Soon Be In Place For Explosive Growth - At Least 50% Upside
12/24/2013 9:45:00 AM - Seeking Alpha

Orphan Drug Designations: Why You Should Care
12/12/2013 10:23:00 AM - Seeking Alpha

Myriad, Janssen Partner on BRACAnalysis - Analyst Blog
12/10/2013 7:23:25 PM - Zacks.com

BioMarin Seeks Canadian Approval - Analyst Blog
12/5/2013 12:50:01 PM - Zacks.com

Biotech Stock Roundup: EU News Boosts Biogen, Gilead & Celgene - Analyst Blog
11/27/2013 11:01:01 AM - Zacks.com

Myriad, BioMarin Collaborate Again - Analyst Blog
11/22/2013 6:05:01 PM - Zacks.com

US Stocks: Short This Market With Care
11/21/2013 10:35:00 AM - Minyanville

FDA Panel Positive on BioMarin's Vimizim - Analyst Blog
11/20/2013 12:50:01 PM - Zacks.com

BioMarin Shoots Up Ahead of FDA Panel - Analyst Blog
11/18/2013 12:30:01 PM - Zacks.com

BioMarin Pharmaceutical (BMRN) in Focus: Stock Jumps 7.7% - Tale of the Tape
11/18/2013 10:32:01 AM - Zacks.com

Pre-Market Most Active for Nov 15, 2013 : TMUS, NOK, SMFG, BAC, VNDA, BMRN, PFE, MET, SLM, MHLD, AGNC, CSCO
11/15/2013 9:39:41 AM - NASDAQ.com News

Biotechs With FDA Review Dates In November 2013
10/25/2013 1:23:00 PM - Seeking Alpha

Loss at BioMarin Wider Than Expected - Analyst Blog
10/25/2013 11:07:08 AM - Zacks.com

Sector Update: Healthcare Higher Pre-Market; ImmunoGen Spikes 7% on Earnings
10/25/2013 8:52:46 AM - MT Newswires

Sector Update: Healthcare
10/25/2013 8:45:18 AM - MT Newswires

4 Pharma Stocks Set to Deliver Earnings Surprises - Earnings ESP
10/22/2013 1:07:07 PM - Zacks.com

Cramer's Lightning Round - It's Stupid That No One Bought Kodiak (10/21/13)
10/22/2013 6:13:00 AM - Seeking Alpha